A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
2d
News Medical on MSNJumbled Proteins Paint a Bold Target on the Backs of Brain TumorsImmune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...
Discover how Akron Children's is using Abridge's AI platform to reduce cognitive load and bring joy back to pediatric care, with plans for specialty expansion.
Mara Sherman, PhD, was awarded the Mark Foundation 2025 Emerging Leader Award, which honored five early-career scientists ...
54mon MSN
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results